Randomized Trial of Systemic Therapy After Involved-Field Radiotherapy in Patients With Early-Stage Follicular Lymphoma: TROG 99.03
Michael MacManus, Richard Fisher, Daniel Roos, Peter O'Brien, Andrew Macann, Sidney Davis, Richard Tsang, David Christie, Bev McClure, David Joseph, Jayasingham Jayamohan, John F Seymour
Journal of Clinical Oncology | AMER SOC CLINICAL ONCOLOGY | Published : 2018
Supported by the Cancer Council of Victoria, with additional funding contributed by the Australasian Leukaemia and Lymphoma Group, Peter MacCallum Cancer Centre, Amgen, and Roche. Roche also supplied the rituximab used in the amended version of the trial. Quality assurance for the trial was supported by a grant from the Australian Federal Department of Health.